TY  - GEN
AU  - Sagers,Jessica E
AU  - Beauchamp,Roberta L
AU  - Zhang,Yanling
AU  - Vasilijic,Sasa
AU  - Wu,Limeng
AU  - DeSouza,Patrick
AU  - Seist,Richard
AU  - Zhou,Wenjianlong
AU  - Xu,Lei
AU  - Ramesh,Vijaya
AU  - Stankovic,Konstantina M
TI  - Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma
SN  - 2045-2322
PY  - 2020///1123
KW  - Animals
KW  - Benzamides
KW  - pharmacology
KW  - Dasatinib
KW  - Disease Models, Animal
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Morpholines
KW  - Neurofibromin 2
KW  - genetics
KW  - Neuroma, Acoustic
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Receptor, EphA1
KW  - metabolism
KW  - TOR Serine-Threonine Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1038/s41598-020-60156-6
ER  -